|
Parent Compound
|
Method
|
Matrix
|
LLOQ
|
|
Aztreonam
|
LC/MS/MS
|
Human Plasma
|
0.2 µg/mL
|
|
Aztreonam
|
LC/MS/MS
|
Human Urine
|
0.2 µg/mL
|
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.25 μg/ml
|
|
Cefepime and Tazobactam
|
LC/MS/MS
|
Human Urine
|
15 & 45 μg/mL
|
|
Cefiderocol
|
LC/MS/MS
|
Human BAL
|
0.005 µg/mL
|
|
Cefiderocol
|
LC/MS/MS
|
Human Plasma
|
0.1 µg/mL
|
|
Cefiderocol
|
LC/MS/MS
|
Dialysate
|
0.2 µg/mL
|
|
Cefiderocol
|
LC/MS/MS
|
Bovine Plasma
|
0.2 µg/mL
|
|
Ceftaroline
|
|
Human Plasma & Serum
|
|
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
Human Na2EDTA/NaF Plasma
|
|
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
Human Urine
|
0.5 µg/mL
|
|
Ceftaroline and Metabolites
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Cell Culture Medium
|
|
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
Human Sputum
|
|
|
Ceftazidime and Avibactam
|
LC/MS/MS
|
NaF/KOx Human Plasma
|
|
|
Cilastatin & Imipenem
|
LC/MS/MS
|
K2EDTA Human Plasma
|
50 ng/mL
|
|
Clarithromycin
|
LC/MS/MS
|
Human Plasma
|
10 ng/mL
|
|
Clarithromycin
|
LC/MS/MS
|
Human BAL
|
1 ng/mL
|
|
Colistin
|
|
Cell Media
|
|
|
Colistin
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
|
Colistin
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
|
Colistin
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Human Urine
|
10 ng/mL
|
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
K2EDTA Rat Plasma
|
10 ng/mL
|
|
Colistin Methanesulfonate (Free and Total)
|
LC/MS/MS
|
Rat Lung
|
100 ng/g
|
|
Dalbavancin
|
LC/MS/MS
|
Cell Medium
|
|
|
Dalbavancin
|
LC/MS/MS
|
Human Plasma
|
|
|
Dalbavancin
|
|
Rabbit Serum
|
|
|
Dapsone, N-acetyl Dapsone and N-hydroxy Dapsone
|
LC/MS/MS
|
K3EDTA Human Plasma with Ascorbic Acid
|
|
|
Dapsone, N-acetyl Dapsone and N-hydroxylamine Dapsone
|
LC/MS/MS
|
Human Plasma
|
|
|
Delafloxacin
|
LC/MS/MS
|
Human BAL
|
0.1 ng/mL
|
|
Doripenem
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
0.1μg/ml
|
|
Fosfomycin
|
LC/MS/MS
|
Human Urine
|
|
|
Fosfomycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
Moxifloxocin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
Nafithromycin
|
LC/MS/MS
|
Human Plasma
|
|
|
Nafithromycin and N-desmethyl-Nafithromycin
|
LC/MS/MS
|
K2EDTA Human Plasma
|
|
|
Omadacycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
|
Omadacycline
|
HPLC
|
Dosing Solution
|
|
|
Omadacycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
|
Omadacycline
|
LC/MS/MS
|
Rat Heparin Plasma
|
|
|
Omadacycline
|
LC/MS/MS
|
Rat Plasma
|
|
|
Piperacillin, Meropenem, & Tazobactam
|
LC/MS/MS
|
Rabbit Plasma
|
0.1 µg/mL
|
|
Piperacillin, Meropenem, & Tazobactam
|
LC/MS/MS
|
K2EDTA Human Plasma
|
0.2 µg/mL
|
|
Sulbactam sodium and EXT2514
|
LC/MS/MS
|
Human BAL
|
2 ng/mL
|
|
Tebipenem
|
LC/MS/MS
|
Human BAL
|
1 ng/mL
|
|
Tigecycline
|
LC/MS/MS
|
Acidified Human Cell Pellet
|
|
|
Tigecycline
|
LC/MS/MS
|
Human Cell Pellet
|
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL
|
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human BAL AM Pellet and BAL ELF
|
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Sodium Heparin Plasma
|
|
|
Zidebactam and Cefepime
|
LC/MS/MS
|
Human Urine
|
|
Keystone Bioanalytical